Segment reporting (Tables)

9 Months Ended

May 31, 2022

Segment Reporting [Abstract]

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reflects results of operations of the Company’s reportable segments (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2022		2021		2022		2021
Sales:
United States	$	26,695	$	28,743	$	82,394	$	83,250
International	5,305		5,288		16,686		14,998
Walgreens Health	596		—		1,173		—
Corporate and Other 1	1		—		—		—
Walgreens Boots Alliance, Inc.	$	32,597	$	34,030	$	100,254	$	98,247
Adjusted operating income:
United States	$	966	$	1,471	$	4,243	$	3,789
International	174		94		563		326
Walgreens Health	(129)		(17)		(218)		(31)
Corporate and Other	(56)		(88)		(198)		(202)
Walgreens Boots Alliance, Inc.	$	955	$	1,459	$	4,389	$	3,881

1.Includes certain eliminations.

The following table reconciles adjusted operating income to operating (loss) income (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2022		2021		2022		2021
Adjusted operating income	$	955	$	1,459	$	4,389	$	3,881
Adjustments to equity earnings (loss) in AmerisourceBergen	(60)		(48)		(155)		(1,575)
Transformational cost management	(185)		(60)		(458)		(338)
Acquisition-related amortization	(201)		(158)		(616)		(367)
Certain legal and regulatory accruals and settlements	(734)		—		(734)		(60)
LIFO provision	(55)		(51)		(64)		(85)
Acquisition-related costs	(40)		(9)		(155)		(25)
Operating (loss) income	$	(320)	$	1,134	$	2,209	$	1,432